ArticlePlacenta2025
AHR activated placental adrenomedullin: A plausible factor in smoke-induced preeclampsia protection.
Article in Placenta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Role of microbial metabolites in the pathogenesis of hypertensive disorders of pregnancy: From short‑chain fatty acids to tryptophan metabolites (Review).Molecular medicine reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionThe placenta develops as trophectoderm cells invade and secrete peptides to remodel the maternal vasculature. Impaired invasion can lead to preeclampsia. Maternal smoking during pregnancy can cause miscarriage and fetal developmental problems. Yet curiously, cigarette use during pregnancy correlates with a decreased risk for preeclampsia. To explore this, we have studied the secreted peptide, adrenomedullin (ADM) that promotes placentation and is increased by maternal smoking. The aryl hydrocarbon receptor (AHR) is a transcription factor that binds cigarette-associated carcinogenic ligands. We hypothesized that AHR activation by cigarette smoke induces Adm to promote placental development.
methodsPregnant transgenic animals exhibiting overexpression of Adm or genetic loss of Ahr were exposed to cigarette smoke. Embryo and placenta tissues were evaluated. Immortalized trophoblast cells (HTR8/SVneo) were also exposed to cigarette smoke extract before AHR chromatin immunoprecipitation with quantitative polymerase chain reaction.
resultsAblation of Ahr reduced embryo weights and embryo/placental weight ratios. Further, overexpression of Adm increased placental weights in sham treated conditions yet caused abnormal placental growth and stunted embryo development with cigarette smoke. Finally, chromatin immunoprecipitation results demonstrated that AHR significantly binds to two sites on the ADM promoter. DISCUSSION: In a mouse model of high Adm expression, cigarette smoke can elicit stunted embryo and placental weights and abnormal placental morphology. Thus, tightly regulated ADM levels are critical for murine gestational development and in the presence of cigarette smoke, are promoted by AHR-mediated transcriptional activation. These studies provide compelling results suggesting AHR drives ADM upregulation in the smoke-exposed placenta.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.